Novel lipid-lowering agents

Zahid Ahmad; Abhimanyu Garg

doi:10.1007/978-1-60761-424-1_30

Novel lipid-lowering agents

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Lipid-lowering drugs are the second most commonly prescribed medication class in the USA with statins being the most commonly prescribed agent within this class. The widespread use of statins owes to overwhelming evidence of benefit and safety as well as awareness campaigns directed at both the physicians and consumers.

Original language	English (US)
Title of host publication	Dyslipidemias: Pathophysiology, Evaluation and Management
Publisher	Humana Press Inc.
Pages	499-519
Number of pages	21
ISBN (Print)	9781607614241, 9781607614234
DOIs	https://doi.org/10.1007/978-1-60761-424-1_30
State	Published - Jan 1 2015

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-60761-424-1_30

Cite this

@inbook{f0ebe94239104045b0b56731f2c21ec4,

title = "Novel lipid-lowering agents",

abstract = "Lipid-lowering drugs are the second most commonly prescribed medication class in the USA with statins being the most commonly prescribed agent within this class. The widespread use of statins owes to overwhelming evidence of benefit and safety as well as awareness campaigns directed at both the physicians and consumers.",

author = "Zahid Ahmad and Abhimanyu Garg",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-1-60761-424-1_30",

language = "English (US)",

isbn = "9781607614241",

pages = "499--519",

booktitle = "Dyslipidemias: Pathophysiology, Evaluation and Management",

publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Novel lipid-lowering agents

AU - Ahmad, Zahid

AU - Garg, Abhimanyu

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Lipid-lowering drugs are the second most commonly prescribed medication class in the USA with statins being the most commonly prescribed agent within this class. The widespread use of statins owes to overwhelming evidence of benefit and safety as well as awareness campaigns directed at both the physicians and consumers.

AB - Lipid-lowering drugs are the second most commonly prescribed medication class in the USA with statins being the most commonly prescribed agent within this class. The widespread use of statins owes to overwhelming evidence of benefit and safety as well as awareness campaigns directed at both the physicians and consumers.

UR - http://www.scopus.com/inward/record.url?scp=84956831051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956831051&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-424-1_30

DO - 10.1007/978-1-60761-424-1_30

M3 - Chapter

AN - SCOPUS:84956831051

SN - 9781607614241

SN - 9781607614234

SP - 499

EP - 519

BT - Dyslipidemias: Pathophysiology, Evaluation and Management

PB - Humana Press Inc.

ER -

Novel lipid-lowering agents

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this